- Deritas 7.5 mg Tablet effectively alleviates symptoms of Overactive Bladder (OAB).
- This medication reduces the frequency of urination, providing patients with greater comfort.
- Deritas 7.5 mg Tablet helps manage the urgent need to urinate, enhancing daily life quality.
- By relaxing bladder muscles, Deritas 7.5 mg Tablet minimizes involuntary urine leakage.
- Patients using Deritas 7.5 mg Tablet may experience improved bladder control over time.
- Deritas 7.5 mg Tablet is beneficial for individuals who struggle with nighttime urination.
- This formulation supports better bladder capacity, allowing for longer intervals between bathroom visits.
- Deritas 7.5 mg Tablet is suitable for adults experiencing OAB symptoms.
- Using Deritas 7.5 mg Tablet can lead to increased confidence in social situations.
- Deritas 7.5 mg Tablet may help reduce anxiety related to frequent restroom visits.
- Patients often report a significant decrease in urgency after starting Deritas 7.5 mg Tablet.
- Deritas 7.5 mg Tablet contributes to an overall improvement in urinary health.
- This medication can be part of a comprehensive treatment plan for OAB.
- Deritas 7.5 mg Tablet is easy to incorporate into daily routines.
- With consistent use, Deritas 7.5 mg Tablet can lead to long-term symptom management.
Deritas 7.5 mg Tablet - Strip of 10
Compositions : Darifenacin 7.5mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Intas Pharmaceuticals Ltd.
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Deritas 7.5 mg Tablet is a pharmaceutical formulation specifically designed to address the symptoms associated with Overactive Bladder (OAB). This medication contains the active ingredient Darifenacin, which belongs to the antimuscarinic class of drugs. Deritas 7.5 mg Tablet works by relaxing the muscles of the urinary bladder, thereby reducing the frequency and urgency of urination. The primary purpose of Deritas 7.5 mg Tablet is to provide relief from the discomfort and inconvenience caused by OAB, which can significantly impact a person's quality of life. The therapeutic category of Deritas 7.5 mg Tablet includes urinary antispasmodics, making it an effective choice for individuals suffering from this condition. The key composition of Deritas 7.5 mg Tablet includes Darifenacin, which is known for its efficacy in managing urinary symptoms. By targeting the underlying mechanisms of OAB, Deritas 7.5 mg Tablet helps patients regain control over their bladder function. This medication is particularly beneficial for those experiencing frequent urination, an urgent need to urinate, and involuntary loss of urine control. With its carefully formulated dosage, Deritas 7.5 mg Tablet aims to enhance the overall bladder capacity and reduce the urgency associated with OAB symptoms. Patients using Deritas 7.5 mg Tablet can expect a gradual improvement in their urinary symptoms, allowing them to engage more freely in daily activities without the constant worry of needing to find a restroom. Overall, Deritas 7.5 mg Tablet stands out as a reliable option for managing OAB symptoms effectively and safely.
Product Details
Deritas 7.5 mg Tablet operates through its active ingredient Darifenacin, which is classified as an antimuscarinic agent. This medication specifically targets the receptors in the bladder that are responsible for muscle contractions, leading to relaxation and reduced urgency in urination.
- Darifenacin inhibits the action of acetylcholine on muscarinic receptors in the bladder.
- This inhibition results in decreased bladder muscle contractions.
- By relaxing the bladder muscles, Deritas 7.5 mg Tablet increases bladder capacity.
- The formulation helps prevent involuntary contractions that lead to urgency.
- Darifenacin's action allows for better control over urination.
- Patients may experience fewer episodes of urgent urination with consistent use of Deritas 7.5 mg Tablet.
- The medication effectively manages symptoms associated with OAB by targeting specific pathways in the urinary system.
- Deritas 7.5 mg Tablet should be taken orally with or without food as directed by a healthcare provider.
- The recommended dosage for adults is typically one tablet per day.
- It is advisable to take Deritas 7.5 mg Tablet at the same time each day for optimal results.
- The duration of treatment with Deritas 7.5 mg Tablet will depend on individual response and physician recommendations.
- Do not exceed the prescribed dosage of Deritas 7.5 mg Tablet without consulting a healthcare professional.
- If a dose is missed, take it as soon as remembered unless it is close to the next scheduled dose.
- Consult a doctor if symptoms do not improve after several weeks of using Deritas 7.5 mg Tablet.
- Stay hydrated while taking Deritas 7.5 mg Tablet but avoid excessive fluid intake before bedtime to minimize nighttime urination.
- Maintain a balanced diet rich in fiber to help prevent constipation while using Deritas 7.5 mg Tablet.
- Avoid excessive caffeine and alcohol intake as they can aggravate OAB symptoms.
- Stay hydrated but limit fluid intake before bedtime to reduce nighttime urination.
- Engage in regular physical activity to promote overall health and well-being while on Deritas 7.5 mg Tablet.
- Practice pelvic floor exercises to strengthen bladder control alongside using Deritas 7.5 mg Tablet.
Safety Advice
Side Effects
- Common side effects of Deritas 7.5 mg Tablet include dry mouth and constipation.
- Some patients may experience blurred vision while using Deritas 7.5 mg Tablet.
- Headaches can occur as a side effect of Deritas 7.5 mg Tablet usage.
- Dry eyes may also be reported by individuals taking Deritas 7.5 mg Tablet.
- Urinary retention is a potential side effect that requires monitoring during treatment with Deritas 7.5 mg Tablet.
- If any side effects persist or worsen, consult a healthcare provider promptly.
- Serious side effects may include severe allergic reactions; seek immediate medical attention if symptoms occur.
Precautions and Warnings
- Individuals with known hypersensitivity to Darifenacin should avoid using Deritas 7.5 mg Tablet.
- Consult a doctor before using Deritas 7.5 mg Tablet if there are existing liver or kidney conditions.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before taking Deritas 7.5 mg Tablet.
- Avoid alcohol consumption while using Deritas 7.5 mg Tablet as it may exacerbate side effects.
- Caution is advised when driving or operating machinery due to possible blurred vision from Deritas 7.5 mg Tablet.
- Inform your doctor about all medications being taken to avoid potential drug interactions with Deritas 7.5 mg Tablet.
- If experiencing severe side effects or allergic reactions, discontinue use and seek medical help immediately.
FAQs
Deritas 7.5 mg Tablet is primarily used for treating Overactive Bladder (OAB) symptoms such as frequent urination and urgency.
2. How should I take Deritas 7.5 mg Tablet?
Deritas 7.5 mg Tablet should be taken orally once daily, with or without food, as directed by your healthcare provider.
3. What are the common side effects of Deritas 7.5 mg Tablet?
Common side effects include dry mouth, constipation, blurred vision, headaches, and urinary retention.
4. Can I drink alcohol while taking Deritas 7.5 mg Tablet?
It is advisable to avoid alcohol while taking Deritas 7.5 mg Tablet as it may worsen side effects.
5. Is there anyone who should not use Deritas 7.5 mg Tablet?
Individuals with hypersensitivity to Darifenacin or those with certain liver or kidney conditions should avoid using Deritas 7.5 mg Tablet.
6. How does Deritas 7.5 mg Tablet work?
Deritas 7.5 mg Tablet works by relaxing the muscles of the urinary bladder, which helps reduce urgency and frequency of urination.
7. What should I do if I miss a dose of Deritas 7.5 mg Tablet?
If you miss a dose of Deritas 7.5 mg Tablet, take it as soon as you remember unless it's close to your next scheduled dose.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 146010 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Intas Pharmaceuticals Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Deritas 7.5 mg Tablet is a pharmaceutical formulation specifically designed to address the symptoms associated with Overactive Bladder (OAB). This medication contains the active ingredient Darifenacin, which belongs to the antimuscarinic class of drugs. Deritas 7.5 mg Tablet works by relaxing the muscles of the urinary bladder, thereby reducing the frequency and urgency of urination. The primary purpose of Deritas 7.5 mg Tablet is to provide relief from the discomfort and inconvenience caused by OAB, which can significantly impact a person's quality of life. The therapeutic category of Deritas 7.5 mg Tablet includes urinary antispasmodics, making it an effective choice for individuals suffering from this condition. The key composition of Deritas 7.5 mg Tablet includes Darifenacin, which is known for its efficacy in managing urinary symptoms. By targeting the underlying mechanisms of OAB, Deritas 7.5 mg Tablet helps patients regain control over their bladder function. This medication is particularly beneficial for those experiencing frequent urination, an urgent need to urinate, and involuntary loss of urine control. With its carefully formulated dosage, Deritas 7.5 mg Tablet aims to enhance the overall bladder capacity and reduce the urgency associated with OAB symptoms. Patients using Deritas 7.5 mg Tablet can expect a gradual improvement in their urinary symptoms, allowing them to engage more freely in daily activities without the constant worry of needing to find a restroom. Overall, Deritas 7.5 mg Tablet stands out as a reliable option for managing OAB symptoms effectively and safely.
- Deritas 7.5 mg Tablet effectively alleviates symptoms of Overactive Bladder (OAB).
- This medication reduces the frequency of urination, providing patients with greater comfort.
- Deritas 7.5 mg Tablet helps manage the urgent need to urinate, enhancing daily life quality.
- By relaxing bladder muscles, Deritas 7.5 mg Tablet minimizes involuntary urine leakage.
- Patients using Deritas 7.5 mg Tablet may experience improved bladder control over time.
- Deritas 7.5 mg Tablet is beneficial for individuals who struggle with nighttime urination.
- This formulation supports better bladder capacity, allowing for longer intervals between bathroom visits.
- Deritas 7.5 mg Tablet is suitable for adults experiencing OAB symptoms.
- Using Deritas 7.5 mg Tablet can lead to increased confidence in social situations.
- Deritas 7.5 mg Tablet may help reduce anxiety related to frequent restroom visits.
- Patients often report a significant decrease in urgency after starting Deritas 7.5 mg Tablet.
- Deritas 7.5 mg Tablet contributes to an overall improvement in urinary health.
- This medication can be part of a comprehensive treatment plan for OAB.
- Deritas 7.5 mg Tablet is easy to incorporate into daily routines.
- With consistent use, Deritas 7.5 mg Tablet can lead to long-term symptom management.
Deritas 7.5 mg Tablet operates through its active ingredient Darifenacin, which is classified as an antimuscarinic agent. This medication specifically targets the receptors in the bladder that are responsible for muscle contractions, leading to relaxation and reduced urgency in urination.
- Darifenacin inhibits the action of acetylcholine on muscarinic receptors in the bladder.
- This inhibition results in decreased bladder muscle contractions.
- By relaxing the bladder muscles, Deritas 7.5 mg Tablet increases bladder capacity.
- The formulation helps prevent involuntary contractions that lead to urgency.
- Darifenacin's action allows for better control over urination.
- Patients may experience fewer episodes of urgent urination with consistent use of Deritas 7.5 mg Tablet.
- The medication effectively manages symptoms associated with OAB by targeting specific pathways in the urinary system.
- Deritas 7.5 mg Tablet should be taken orally with or without food as directed by a healthcare provider.
- The recommended dosage for adults is typically one tablet per day.
- It is advisable to take Deritas 7.5 mg Tablet at the same time each day for optimal results.
- The duration of treatment with Deritas 7.5 mg Tablet will depend on individual response and physician recommendations.
- Do not exceed the prescribed dosage of Deritas 7.5 mg Tablet without consulting a healthcare professional.
- If a dose is missed, take it as soon as remembered unless it is close to the next scheduled dose.
- Consult a doctor if symptoms do not improve after several weeks of using Deritas 7.5 mg Tablet.
- Stay hydrated while taking Deritas 7.5 mg Tablet but avoid excessive fluid intake before bedtime to minimize nighttime urination.
- Maintain a balanced diet rich in fiber to help prevent constipation while using Deritas 7.5 mg Tablet.
- Avoid excessive caffeine and alcohol intake as they can aggravate OAB symptoms.
- Stay hydrated but limit fluid intake before bedtime to reduce nighttime urination.
- Engage in regular physical activity to promote overall health and well-being while on Deritas 7.5 mg Tablet.
- Practice pelvic floor exercises to strengthen bladder control alongside using Deritas 7.5 mg Tablet.
Side Effects
- Common side effects of Deritas 7.5 mg Tablet include dry mouth and constipation.
- Some patients may experience blurred vision while using Deritas 7.5 mg Tablet.
- Headaches can occur as a side effect of Deritas 7.5 mg Tablet usage.
- Dry eyes may also be reported by individuals taking Deritas 7.5 mg Tablet.
- Urinary retention is a potential side effect that requires monitoring during treatment with Deritas 7.5 mg Tablet.
- If any side effects persist or worsen, consult a healthcare provider promptly.
- Serious side effects may include severe allergic reactions; seek immediate medical attention if symptoms occur.
Precautions and Warnings
- Individuals with known hypersensitivity to Darifenacin should avoid using Deritas 7.5 mg Tablet.
- Consult a doctor before using Deritas 7.5 mg Tablet if there are existing liver or kidney conditions.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before taking Deritas 7.5 mg Tablet.
- Avoid alcohol consumption while using Deritas 7.5 mg Tablet as it may exacerbate side effects.
- Caution is advised when driving or operating machinery due to possible blurred vision from Deritas 7.5 mg Tablet.
- Inform your doctor about all medications being taken to avoid potential drug interactions with Deritas 7.5 mg Tablet.
- If experiencing severe side effects or allergic reactions, discontinue use and seek medical help immediately.
Deritas 7.5 mg Tablet is primarily used for treating Overactive Bladder (OAB) symptoms such as frequent urination and urgency.
2. How should I take Deritas 7.5 mg Tablet?
Deritas 7.5 mg Tablet should be taken orally once daily, with or without food, as directed by your healthcare provider.
3. What are the common side effects of Deritas 7.5 mg Tablet?
Common side effects include dry mouth, constipation, blurred vision, headaches, and urinary retention.
4. Can I drink alcohol while taking Deritas 7.5 mg Tablet?
It is advisable to avoid alcohol while taking Deritas 7.5 mg Tablet as it may worsen side effects.
5. Is there anyone who should not use Deritas 7.5 mg Tablet?
Individuals with hypersensitivity to Darifenacin or those with certain liver or kidney conditions should avoid using Deritas 7.5 mg Tablet.
6. How does Deritas 7.5 mg Tablet work?
Deritas 7.5 mg Tablet works by relaxing the muscles of the urinary bladder, which helps reduce urgency and frequency of urination.
7. What should I do if I miss a dose of Deritas 7.5 mg Tablet?
If you miss a dose of Deritas 7.5 mg Tablet, take it as soon as you remember unless it's close to your next scheduled dose.
Directions for Use
Storage and Disposal
| SKU | 146010 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Intas Pharmaceuticals Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account